Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial Journal Articles Refereed uri icon

Overview

Authors

  • Authorship

    • SHAW AT
    • JAMES LP
    • CLANCY JS
    • CHEN J
    • MARTINI J-F
    • ABBATTISTA A
    • PROF Benjamin Solomon
    • FELIP E
    • BAUER TM
    • BESSE B
    • NAVARRO A
    • POSTEL-VINAY S
    • GAINOR JF
    • JOHNSON M
    • DIETRICH J

Published in

  • Lancet Oncology

Time

Date/time value

  • 2017

Identity

Digital Object Identifier (DOI)

  • 10.1016/S1470-2045(17)30680-0

Additional Document Info

Parent Title

  • LANCET ONCOLOGY

Volume

  • 18

Issue

  • 12

Publisher

  • Lancet